News

BioPharm Systems, a global IT consulting and managed services provider in the life sciences industry, has been acquired by Perficient.

Perficient announced it has acquired BioPharm Systems, Inc.

The European Medicines Agency is determined to minimize opposition to its next moves on releasing clinical trial data.

Firecrest platform offers unique capabilities for improving the quality, consistency, and compliance of ICH/GCP

ICON announced that TransCelerate has certified its Firecrest GCP training as mutually acceptable for its members.

RAPS announced a new chapter in Taiwan, which is its first in Asia.

EFGCP is organizing an interactive workshop intended to develop practical strategies and approaches for risk management and risk-based monitoring in clinical trials

Linking Leaders, host of invitation-only roundtable forums for clinical trial executives, has witnessed the rapid advancement of quality approaches supporting modern clinical trials.

While the biopharmaceutical industry faces challenges in regulation, standardization, and change, CROs are often in the middle of the change.

An agreement between ERT and GE Healthcare has the former integrating the latter's QT Guard Plus Algorithm tool

DIA China has appointed biopharmaceutical executive Haijun (Lou) Dong, PhD, as its managing director.

Targeted discussions with key stakeholders in May

EMA has revealed that in early May, it will launch a final round of targeted consultations on its draft policy...

Clinical trial budget development continues to frustrate industry sponsors and investigative sites.

Biopharmaceutical executive Dr. Haijun (Lou) Dong has been named as managing director for DIA China.

Novel Approach May Help to Prevent False Positive Cardiac Safety Findings in New Drug Development

Project Data Sphere, an independent not-for-profit initiative, has launched a data sharing platform

The Partnerships in Clinical Trials Conference was a large venue that attracted many high-level executives from biopharmaceutical companies

The overall burden of drug development has increased exponentially over the last decade or so.

Project Data Sphere, LLC, an independent not-for-profit initiative of the CEO Roundtable on Cancer?s Life Sciences Consortium, announced today the launch of a new data sharing platform

Kent Thoelke spoke at the Partnerships conference regarding trial conduct differences in China.

Clinipace Worldwide announced it has entered into a preferred provider agreement with Karyopharm Therapeutics Inc.

Technology-Amplified dCRO Model Accelerating Personalized Approach to Targeted Therapies, Including Greater Collaboration, Higher Data Quality, and Reduced Development Costs

Greenphire announced the launch of a strategic partnership with ERT

Greenphire announced a strategic partnership with ERT

The elderly is the fastest-growing segment of the global population, but only a few of their treatments have been clinically tested in age-appropriate patients

Despite the elderly being the fastest-growing segment of the global population, only a few of their treatments have been clinically trialed in age-appropriate patients

South Korean pharmaceutical industry value to grow from $19.3 billion in 2013 to $24.3 billion by 2020